tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Edgewise Therapeutics Inc

EWTX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
45.320USD
-1.620-3.45%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
4.89B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์žฅ์™ธ ๊ฑฐ๋ž˜ย 16:13ย (ET)45.220USD-0.150-0.33%

EWTX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Edgewise Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
4.89B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-27.34
์ฃผ๋‹น์ˆœ์ด์ต
-1.66
์ˆ˜์ต
--
์ˆœ์ด์ต
-133.81M
ROE
-38.14%
ROA
-36.18%

Edgewise Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
-0.53/-0.47
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-54.71%-0.53
-6.69%-0.46
-13.11%-0.47
-5.96%-0.39
-2.18%-0.34
-31.66%-0.43
10.02%-0.42
10.21%-0.36
0.57%-0.34
9.76%-0.33
-51.79%-0.47
---0.41
---0.34
---0.36
---0.31
---0.96
----
----
----
----
์ˆœ์ด์ต
-58.73%-57.33M
-20.14%-49.01M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.02%
----
----
----
----
์˜์—… ์ด์ต
-45.37%-61.94M
-17.75%-54.12M
-22.92%-55.98M
-15.89%-46.86M
-11.82%-42.61M
-32.24%-45.96M
-34.49%-45.54M
-37.28%-40.43M
-50.39%-38.11M
-35.20%-34.75M
-53.37%-33.86M
-61.27%-29.45M
-53.65%-25.34M
-73.37%-25.70M
-72.20%-22.08M
-39.66%-18.26M
-57.66%-16.49M
-116.22%-14.83M
-102.11%-12.82M
-258.93%-13.08M
์ˆœ์ด์ต
-58.73%-57.33M
-20.14%-49.01M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
์œ ๋™์ž์‚ฐ
-21.84%471.52M
15.03%509.79M
14.28%543.38M
14.91%573.90M
16.14%603.25M
-18.15%443.18M
45.41%475.48M
67.64%499.44M
63.86%519.44M
62.41%541.43M
-8.40%327.00M
-19.51%297.92M
25.13%317.00M
24.10%333.36M
25.80%357.00M
26.22%370.14M
-16.38%253.34M
-13.50%268.62M
--283.77M
--293.24M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
38.98%29.04M
6.76%22.54M
14.71%27.37M
14.18%21.65M
21.66%20.90M
44.62%21.11M
42.27%23.86M
16.03%18.96M
19.28%17.18M
14.83%14.60M
1.12%16.77M
22.81%16.34M
56.25%14.40M
27.10%12.71M
57.64%16.59M
51.96%13.30M
36.76%9.22M
106.23%10.00M
--10.52M
--8.75M
์ด ์ž์‚ฐ
-21.79%479.69M
14.11%518.52M
13.51%552.60M
14.12%583.47M
15.36%613.33M
-17.95%454.39M
43.17%486.82M
64.21%511.28M
60.80%531.65M
59.87%553.81M
-7.37%340.04M
-17.44%311.36M
28.45%330.63M
27.01%346.40M
28.70%367.10M
28.09%377.15M
-15.19%257.40M
-12.37%272.75M
--285.23M
--294.45M
๋ถ€์ฑ„ ์ด๊ณ„
30.28%31.61M
2.62%25.32M
9.95%30.35M
10.77%24.82M
14.59%24.26M
30.78%24.67M
30.16%27.60M
7.01%22.41M
10.45%21.17M
7.43%18.86M
4.02%21.20M
32.94%20.94M
73.58%19.17M
41.74%17.56M
87.88%20.39M
74.04%15.75M
63.88%11.04M
155.39%12.39M
--10.85M
--9.05M
์ž๋ณธ ์ด๊ณ„
-23.93%448.08M
14.77%493.20M
13.73%522.26M
14.27%558.65M
15.40%589.07M
-19.67%429.72M
44.03%459.22M
68.33%488.88M
63.90%510.47M
62.68%534.94M
-8.04%318.83M
-19.64%290.43M
26.43%311.45M
26.30%328.84M
26.36%346.72M
26.63%361.40M
-16.98%246.35M
-15.03%260.36M
--274.38M
--285.40M
์ˆœ์˜์—…์ด์ต
-30.34%-42.47M
-12.35%-42.54M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.10M
-25.29%-28.60M
-126.99%-26.83M
-83.85%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-25.49%-11.82M
-45.22%-12.00M
-66.29%-16.25M
-107.56%-12.57M
-103.08%-9.42M
-152.51%-8.26M
์ˆœํˆฌ์ž
148.40%78.49M
-94.46%2.43M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.90M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
135.69%26.98M
188.97%23.42M
7582.61%3.44M
56.25%49.04M
-635.34%-75.60M
16.73%-26.32M
99.97%-46.00K
148.46%31.39M
158.40%14.12M
-526700.00%-31.61M
์ˆœ์žฌ๋ฌดํ™œ๋™
-98.36%3.09M
447.59%12.17M
37.31%3.98M
-50.23%1.66M
9542.98%188.23M
-99.08%2.22M
-94.54%2.90M
1679.62%3.33M
429.00%1.95M
1147866.67%241.07M
15776.63%52.99M
-100.16%-211.00K
106.15%369.00K
-71.23%21.00K
-215.36%-338.00K
350508.11%129.72M
119.98%179.00K
-99.96%73.00K
-99.69%293.00K
-99.85%37.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Edgewise Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 543.38M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 14.28์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 552.60M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.51์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 30.35M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.95์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 522.26M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.73์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -191.41M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -20.51์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -32.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 82.24์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Edgewise Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 196.09M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.33์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.63์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -12.58์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -167.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -25.40์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -34.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.60์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -32.29์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.25์ž…๋‹ˆ๋‹ค.

Edgewise Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Edgewise Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -191.41M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -20.51์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ